REALIZE-K: MRA Treatment Optimization in HFrEF Plus Hyperkaliemia
In the REALIZE-K trial, sodium zirconium cyclosilicate increased the rate of mineralocorticoid receptor antagonist treatment optimization for patients with heart failure with reduced ejection fraction.